Table 1.
Antimicrobial activity of the newly synthesized compounds.
| MIC (μg/mL) | |||
|---|---|---|---|
| Gram Positive bacteria |
Gram Negative bacteria |
||
| Compound No. | S. aureus | E. coli | P. aeruginosa |
| 3 | 12.5 | 50 | 50 |
| 4 | 25 | 50 | 100 |
| 5a | 12.5 | 25 | 50 |
| 5b | 6.25 | 12.5 | 25 |
| 5c | 12.5 | 25 | 50 |
| 5d | 25 | 50 | 50 |
| 5e | 25 | 50 | 50 |
| 5f | 50 | 100 | 100 |
| 6 | 12.5 | 25 | 50 |
| 7 | 25 | 25 | 50 |
| 8 | 100 | 100 | 100 |
| 9 | 50 | 50 | 100 |
| 10 | 6.25 | 25 | 50 |
| 11 | 6.25 | 12.5 | 50 |
| 12 | 12.5 | 25 | 100 |
| 13 | 12.5 | 25 | 50 |
| 14a | 6.25 | 12.5 | 50 |
| 14b | 3.125 | 6.25 | 25 |
| 14c | 6.25 | 12.5 | 25 |
| 14d | 12.5 | 25 | 50 |
| 14e | 12.5 | 25 | 50 |
| 14f | 25 | 50 | 50 |
| Ciprofloxacin | 2 | 2 | 4 |